Wunderlich Capital Managemnt’s Zimmer Biomet ZBH Stock Holding History

Wunderlich Capital Managemnt’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,755	Closed	-$1.82M	–	92
2021 Q4	$1.82M	Buy	14,755 +498	+3%	+$65.2K	0.81%	62
2021 Q3	$2.03M	Buy	14,257 +516	+4%	+$75.9K	0.98%	53
2021 Q2	$2.15M	Buy	13,741 +74	+0.5%	+$12K	1.09%	50
2021 Q1	$2.12M	Sell	13,667 -224	-2%	-$34.7K	1.16%	46
2020 Q4	$2.08M	Buy	13,891 +12	+0.1%	+$1.7K	1.15%	40
2020 Q3	$1.83M	Buy	13,879 +304	+2%	+$39.7K	1.13%	39
2020 Q2	$1.57M	Buy	13,575 +28	+0.2%	+$3.23K	1.1%	43
2020 Q1	$1.33M	Sell	13,547 -665	-5%	-$87.2K	1.09%	44
2019 Q4	$2.06M	Sell	14,212 -150	-1%	-$20.7K	1.3%	35
2019 Q3	$1.91M	Sell	14,362 -21	-0.1%	-$2.71K	1.32%	39
2019 Q2	$1.64M	Buy	14,383 +662	+5%	+$77.5K	1.09%	48
2019 Q1	$1.7M	Buy	13,721 +96	+0.7%	+$10.9K	1.19%	42
2018 Q4	$1.37M	Sell	13,625 -374	-3%	-$42.1K	1.05%	47
2018 Q3	$1.79M	Sell	13,999 -529	-4%	-$62.9K	1.27%	36
2018 Q2	$1.57M	Buy	14,528 +237	+2%	+$25.8K	1.09%	53
2018 Q1	$1.51M	Buy	14,291 +69	+0.5%	+$8.01K	1.04%	49
2017 Q4	$1.67M	Buy	14,222 +916	+7%	+$104K	1.15%	40
2017 Q3	$1.51M	Sell	13,306 -42	-0.3%	-$4.85K	1.13%	43
2017 Q2	$1.66M	Sell	13,348 -147	-1%	-$17.4K	1.24%	28
2017 Q1	$1.6M	Buy	13,495 +220	+2%	+$24.9K	1.25%	31
2016 Q4	$1.33M	Buy	13,275 +270	+2%	+$28.9K	1.08%	54
2016 Q3	$1.64M	Sell	13,005 -109	-0.8%	-$13.5K	1.31%	22
2016 Q2	$1.53M	Buy	13,114 +54	+0.4%	+$6.11K	1.3%	21
2016 Q1	$1.35M	Buy	13,060 +272	+2%	+$26.3K	1.16%	45
2015 Q4	$1.27M	Sell	12,788 -66	-0.5%	-$6.46K	1.09%	45
2015 Q3	$1.17M	Buy	+12,854	New	+$1.29M	1.08%	48

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wunderlich Capital Managemnt's ZBH Position: Q1 2022 in Review

Wunderlich Capital Managemnt sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 14,755 shares — an estimated $1.82M sold.

Wunderlich Capital Managemnt first reported a position in ZBH in Q3 2015 and held it in 26 quarters. The position peaked at $2.15M in Q2 2021. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Wunderlich Capital Managemnt reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Wunderlich Capital Managemnt sold 14,755 Zimmer Biomet shares in Q1 2022, an estimated $1.82M.
Wunderlich Capital Managemnt first reported a position in Zimmer Biomet in Q3 2015 and held it in 26 quarters.
Wunderlich Capital Managemnt's Zimmer Biomet position peaked at $2.15M in Q2 2021.
978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Wunderlich Capital Managemnt's 13F filing for Q1 2022, filed 16 May 2022.